Scarica l'app Stockscreener
9.21
5.86%
0.51
Dopo l'orario di chiusura:
9.27
0.06
+0.65%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Storia dei dividendi
Organon Co Borsa (OGN) Ultime notizie
AAD recommends Organon’s VTAMA cream for pediatric atopic dermatitis - Investing.com
Organon’s VTAMA® (tapinarof) cream, 1%, Granted Strong Recommendation in the 2026 American Academy of Dermatology Guidelines for Pediatric Atopic Dermatitis - Business Wire
Organon & Co. Shares Drop 6.4% as Analysts Forecast Weak Growth - National Today
Organon (OGN) Stock Drops Despite Market Gains: Important Facts to Note - Yahoo Finance
Organon rises as Sun Pharma said to near $12B buyout deal - MSN
3 Reasons to Avoid OGN and 1 Stock to Buy Instead - Yahoo Finance
Organon & Co. (NYSE:OGN) Shares Down 6.4%Time to Sell? - MarketBeat
Unusually active option classes on open April 13th - TipRanks
Organon Takeover At $15? Probably Not, Here's Why (NYSE:OGN) - Seeking Alpha
Organon Stock Skyrockets 28% Following Reports of $12 Billion Buyout Offer From Sun Pharma - TIKR.com
Sun Pharma’s Reported US$12b Bid Recasts Organon’s Risk Reward Profile - Sahm
American pharmaceutical MSD receiving billions in tax benefits in the Netherlands - NL Times
Sun Pharma Officially Denies $12 Billion Organon Acquisition Speculation - scanx.trade
EBIT per share of Organon & Co. – SWB:7XP - TradingView — Track All Markets
Is Organon (OGN) Now An Opportunity After Its Recent Share Price Surge? - Yahoo Finance
Buy or Sell Organon Stock in 2026? Takeover Buzz Lifts Shares 28% as Analysts Stay Cautious - International Business Times Australia
Institutional Money Floods Organon as Analysts Warn and Charts Conflicted - Bitget
Organon (OGN) Climbs 39% on $12-Billion Merger Buzz - Insider Monkey
Key deals this week: Organon, UMG, Whitestone REIT, Gilead and more - Seeking Alpha
Avoiding Lag: Real-Time Signals in (OGN) Movement - Stock Traders Daily
Organon Shares Soar as Sun Pharmaceutical Eyes $12B Deal - timothysykes.com
Morning Movers: Organon jumps after report of Sun Pharmaceutical bid - Yahoo Finance
Sun Pharma Nears Final Offer For Organon In Largest Overseas Bet - Sahm
What does Sun Pharma gain from its $12-billion Organon bid? - MSN
OGN Analyst Rating Maintained at Outperform by BNP Paribas - Meyka
Sun Pharma Submits $12B Bid for Organon, Shares Surge - Intellectia AI
This Women’s Health Company Is Drawing Takeover Interest. The Stock Is Soaring. - Barron's
BNP Paribas Maintains Organon & Co(OGN.US) With Buy Rating, Cuts Target Price to $15 - Moomoo
Morgan Stanley Maintains Organon & Co(OGN.US) With Hold Rating, Maintains Target Price $9 - Moomoo
Organon (OGN) Stock Rockets 41% as Sun Pharma Submits $12B Buyout Proposal - MEXC
Organon (OGN) Stock Surges 41% on $12 Billion Sun Pharma Takeover Bid - MEXC
Organon Shares Surge on $12 Billion Takeover Bid from Sun Pharma - AD HOC NEWS
Sun Pharma readies $12B offer for Organon: report - FirstWord Pharma
Sun Pharma Plans USD 12 Billion Organon Acquisition, Prepares Binding Bid: Report - Medical Dialogues
Organon Rumors Persist Despite Sun’s Fresh Denial - Citeline News & Insights
Potential Acquisition Rumors Keep Organon (OGN) on the Rise - GuruFocus
Organon, CoreWeave, WhiteFiber And Other Big Stocks Moving Higher On Friday - Benzinga
Sun Pharma's $12B Organon Bid Rumors Spark Stock Drop, Debt Fears - Whalesbook
Organon & Co. (OGN) is attracting investor attention: Here is what you should know - MSN
M&A News: Organon Stock (OGN) Surges 26% on Reported Sun Pharma Bid - TipRanks
US Stocks Mixed; Dow Falls Over 100 Points - Benzinga
Organon & Co. (OGN) is Drawing Interest from Investors: Key Information You Need to Know - Bitget
Sun Pharmaceutical to proceed with $12B bid for Organon, Economic Times says - TipRanks
Evercore Maintains Organon & Co(OGN.US) With Hold Rating - 富途牛牛
Sun says Organon takeover report ‘speculative in nature’ - TipRanks
Organon deal interest report bodes well for sector valuation, says Evercore ISI - TipRanks
Organon Stock Explodes 17% on Takeover Speculation as Women's Health Drugmaker Draws Buyer Interest - International Business Times Australia
This Women’s Healthcare Stock Is Up 15% on Reports of a Takeover In the Works - Yahoo Finance
Organon’s Phase 3 Data Boosts Vtama Cream’s Market Potential - timothysykes.com
These Stocks Are Today's Movers: Lumentum, Coherent, Sandisk, Palo Alto, Organon, Palantir, and More -- Barrons.com - Moomoo
Organon & Co. (OGN) is Attracting Investor Attention: Here is What You Should Know - Yahoo Finance
OGN stock surges 20% pre-market, on track to break 200-DMA – why this buyout report has caught investor attention - MSN
OGN Stock Surges 20% Pre-Market, On Track To Break 200-DMA – Why This Buyout Report Has Caught Investor Attention - Stocktwits
Organon rises as Sun Pharma nears buyout deal (OGN:NYSE) - Seeking Alpha
US Premarket Movers: CoreWeave, Docusign, Lumentum, Organon - Bloomberg.com
Organon shares jump on reports of potential $12 billion bid from Sun Pharma - MSN
Organon shares surge 8.4% on report of Sun Pharma’s $12 billion bid - Investing.com
Organon shares surge 8.4% on report of Sun Pharma’s $12 billion bid By Investing.com - Investing.com South Africa
0.30%
0.48%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):